10,252 people in their twenties in US test positive for COVID-19 during week ending December 29. History. //--> Mr. Lee’s last day of … Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. The company has generated returns on investments over the last 12 months (-26.10%). Following the transaction, the insider now directly holds 68442.0 shares of the SGMO stock. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. It is understandable that investor optimism is growing ahead of the company’s current quarter results. The stock traded as high as $11.76 and last traded at $11.52. It applies cell and gene therapy to combat haemophilia and other genetic diseases. Still, SEC filings show that on Dec 17, Ramasastry Saira (Director) disposed off 10,000 shares at an average price of $13.27 for $0.13 million. Mogrify and Sangamo announce collaboration and exclusive license agreement for Mogrify's iPSC- and ESC-derived regulatory T cells (SGMO, Press Releases / Tue, 06:00am) Friday, April 17, 2020 The most recent transaction is an insider sale by Ramelmeier Rolf Andrew, the company’s EVP, Technical Operations. [CDATA[// >